In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Amgen's current price sits 24.8% below the high-confidence fair value of $574.36, indicating potential undervaluation. Strong profitability and growth contrast with low leverage, but high Monte Carlo volatility (184.89% CV) signals significant risk. Diverse valuation methods yield wide price ranges, reflecting uncertainty and opportunity.